Aclaris Therapeutics Inc (ACRS) Insider Trading
- $50,995,596.97
- $87,229,203.38
- Oct. 23, 2023
- Joseph Monahan
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 2, 2017 | Major Shareholder | 425,000 | $30.82 | Sell | $13,098,500.00 | |
| Jan. 10, 2017 | Director | 750,000 | $28.25 | Sell | $21,187,500.00 | |
| Nov. 18, 2016 | Major Shareholder | 907,828 | $23.03 | Sell | $20,907,278.84 | |
| Oct. 26, 2016 | Insider | 3,912 | $21.83 | Sell | $85,398.96 | |
| Sept. 28, 2016 | Insider | 1,841 | $24.66 | Sell | $45,399.06 | |
| Sept. 16, 2016 | Major Shareholder | 525,550 | $24.19 | Sell | $12,713,054.50 | |
| Aug. 26, 2016 | Insider | 3,738 | $20.35 | Sell | $76,068.30 | |
| Feb. 23, 2016 | Major Shareholder | 39,726 | $17.15 | Buy | $681,300.90 | |
| Jan. 20, 2016 | Major Shareholder | 7,803 | $19.87 | Buy | $155,045.61 | |
| Jan. 13, 2016 | Major Shareholder | 15,637 | $19.10 | Buy | $298,666.70 | |
| Oct. 29, 2015 | Major Shareholder | 244,200 | $14.00 | Buy | $3,418,800.00 | |
| Oct. 22, 2015 | Major Shareholder | 5,410 | $14.03 | Buy | $75,902.30 | |
| Oct. 21, 2015 | Major Shareholder | 34,999 | $14.89 | Buy | $521,135.11 | |
| Oct. 14, 2015 | Major Shareholder | 42,813 | $14.06 | Buy | $601,950.78 | |
| Oct. 13, 2015 | Major Shareholder | 409,090 | $11.00 | Buy | $4,499,990.00 | |
| Oct. 13, 2015 | Director | 454,545 | $11.00 | Buy | $4,999,995.00 | |
| Oct. 13, 2015 | Insider | 335,455 | $11.00 | Buy | $3,690,005.00 | |
| Oct. 8, 2015 | Major Shareholder | 2,237,130 | $10.86 | Buy | $24,295,231.80 | |
| Oct. 7, 2015 | Major Shareholder | 13,352 | $11.00 | Buy | $146,872.00 |
Insiders are both buying and selling Aclaris Therapeutics Inc stock.
The insider traders at Aclaris Therapeutics Inc are: Kamil Ali-Jackson, Ra Capital Management, Llc, Joseph Monahan, Neal Walker, Andrew N Schiff, Frank Ruffo, James E Flynn, Stephen A Tullman, Anand Mehra, Ventures Fund Vii L.P. Vivo, James Loerop, David N Gordon, Vivo Ventures Vii, Llc, Andrew Kenneth William Powell, Andrew N. Schiff, Douglas J Manion, Fmr Llc, Kevin Balthaser, Sofinnova Venture Partners Vii, and Albert Cha
The most active insider trader at Aclaris Therapeutics Inc is Kamil Ali-Jackson with 9 trades.
Ventures Fund Vii L.P. Vivo has sold the most Aclaris Therapeutics Inc stock with a total value of $47,104,278.84.
Ra Capital Management, Llc has bought the most Aclaris Therapeutics Inc stock with a total value of $30,729,334.10.
The most recent insider trade for Aclaris Therapeutics Inc was on Oct. 23, 2023.
The single biggest insider buy for Aclaris Therapeutics Inc was from Ra Capital Management, Llc with a total value of $24,295,231.80 on Oct. 8, 2015.
The single biggest insider sell for Aclaris Therapeutics Inc was from Anand Mehra with a total value of $21,187,500.00 on Jan. 10, 2017.